New Tranche 1 and Tranche 2 warrants for existing equity
Company: Core Scientific
The claim, verbatim
Existing equity is to receive Tranche 1 warrants for 30% of equity (strike at $1,875 million TEV, 3-year term) and Tranche 2 warrants for 20% of equity (strike at $2,500 million TEV, 5-year term).
Source (primary)
core-scientific 8-K exhibit (d524676dex992.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-11-18)Live source ↗
Quote: “New Tranche 1 Warrants Amount > 30% of equity > Voluntary Exercise: $1,875 million TEV”
How we checked this
Checked on November 20, 2026. The cited source supports every part of this claim.
The term sheet lists both warrant tranches under existing equity treatment. The warrant sections give the stated amounts, strike TEVs and terms.
Confirmed in the source:
- Existing equity is to receive New Tranche 1 and New Tranche 2 warrants
- Tranche 1 warrants cover 30% of equity
- Tranche 1 warrants have a strike at $1,875 million TEV
- Tranche 1 warrants have a 3-year term
- Tranche 2 warrants cover 20% of equity
- Tranche 2 warrants have a strike at $2,500 million TEV
- Tranche 2 warrants have a 5-year term
What we did: Read our cached copy of SEC EDGAR (8-K Ex) (https://www.sec.gov/Archives/edgar/data/1839341/000119312523266221/d524676dex992.htm) in full (18,293 characters, retrieved November 18, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms core-scientific 8-K exhibit (d524676dex992.htm)
Quote: “New Tranche 1 Warrants Amount > 30% of equity > Voluntary Exercise: $1,875 million TEV”